Cargando…
Associating Type 2 Diabetes Risk Factor Genes and FDG-PET Brain Metabolism in Normal Aging and Alzheimer’s Disease
Background: Several studies have linked type 2 diabetes (T2D) to an increased risk of developing Alzheimer’s disease (AD). This has led to an interest in using antidiabetic treatments for the prevention of AD. However, the underlying mechanisms explaining the relationship between T2D and AD have not...
Autores principales: | Nugent, Scott, Potvin, Olivier, Cunnane, Stephen C., Chen, Ting-Huei, Duchesne, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661639/ https://www.ncbi.nlm.nih.gov/pubmed/33192474 http://dx.doi.org/10.3389/fnagi.2020.580633 |
Ejemplares similares
-
Selection of the optimal intensity normalization region for FDG-PET studies of normal aging and Alzheimer’s disease
por: Nugent, Scott, et al.
Publicado: (2020) -
Links Between Metabolic and Structural Changes in the Brain of Cognitively Normal Older Adults: A 4-Year Longitudinal Follow-Up
por: Castellano, Christian-Alexandre, et al.
Publicado: (2019) -
Bias-adjustment in neuroimaging-based brain age frameworks: A robust scheme
por: Beheshti, Iman, et al.
Publicado: (2019) -
Broad learning for early diagnosis of Alzheimer's disease using FDG-PET of the brain
por: Duan, Junwei, et al.
Publicado: (2023) -
(18)F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4–42 Model of Alzheimer’s Disease
por: Bouter, Caroline, et al.
Publicado: (2019)